转化肿瘤学 SCIE

期刊简介估计审稿时候： 较慢,6-12周

Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.

《转化肿瘤学》颁发毗连尝试室和临床环境的新型研讨查询拜访功效，包含危险评估、细胞和份子表征、人类癌症的防备、检测、诊断和医治，整体方针是改良肿瘤患者的临床照顾护士。《转化肿瘤学》将颁发新型医治干涉干与的尝试室研讨和评估癌症新医治形式的临床实验。同业评审的稿件范例包含原始报告、批评和社论。

《Translational Oncology》(转化肿瘤学)编辑部通信体例为STE 800, 230 PARK AVE, NEW YORK, USA, NY, 10169。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。